The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at Commissioner Marty Makary’s request to put it off until after the midterm elections,

Reproductive Freedom for All is throwing its support behind Maine Governor Janet Mills in a heated Democratic Senate primary contest with progressive candidate Graham Platner, Axios has learned. Why it matters: It's the second major abortion-rights organization to back Mills in the race that's pitted leadership against the party's progressive wing.

Abortion medication access, like mifepristone, is unchanged under Trump, but FDA reviews, lawsuits and state enforcement are creating risks for drugmakers.

The ballot measure also includes a ban on gender affirming health care for minors. Judges reissued the summary statement that voters will see on November 2026 ballots to make clear rights were being repealed,